213 related articles for article (PubMed ID: 22268498)
1. mTHPC-mediated photodynamic therapy is effective in the metastatic human 143B osteosarcoma cells.
Reidy K; Campanile C; Muff R; Born W; Fuchs B
Photochem Photobiol; 2012; 88(3):721-7. PubMed ID: 22268498
[TBL] [Abstract][Full Text] [Related]
2. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B
Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293
[TBL] [Abstract][Full Text] [Related]
3. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
4. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light.
Pittet O; Petermann D; Michod D; Krueger T; Cheng C; Ris HB; Widmann C
J Photochem Photobiol B; 2007 Jul; 88(1):29-35. PubMed ID: 17560792
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ
J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991
[TBL] [Abstract][Full Text] [Related]
7. mTHPC-based photodynamic therapy induction of autophagy and apoptosis in cultured cells in relation to mitochondria and endoplasmic reticulum stress.
François A; Marchal S; Guillemin F; Bezdetnaya L
Int J Oncol; 2011 Dec; 39(6):1537-43. PubMed ID: 21874236
[TBL] [Abstract][Full Text] [Related]
8. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.
Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F
Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic efficacy of photodynamic therapy in osteosarcoma cells in vitro.
Meier D; Campanile C; Botter SM; Born W; Fuchs B
J Vis Exp; 2014 Mar; (85):. PubMed ID: 24686859
[TBL] [Abstract][Full Text] [Related]
10. Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Krueger T; Altermatt HJ; Mettler D; Scholl B; Magnusson L; Ris HB
Lasers Surg Med; 2003; 32(1):61-8. PubMed ID: 12516073
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines.
Dragicevic-Curic N; Gräfe S; Gitter B; Fahr A
J Photochem Photobiol B; 2010 Dec; 101(3):238-50. PubMed ID: 20797872
[TBL] [Abstract][Full Text] [Related]
12. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats.
Tsutsui H; MacRobert AJ; Curnow A; Rogowska A; Buonaccorsi G; Kato H; Bown SG
Lasers Med Sci; 2002; 17(2):101-9. PubMed ID: 12111593
[TBL] [Abstract][Full Text] [Related]
14. mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Horlings RK; Terra JB; Witjes MJ
Lasers Surg Med; 2015 Dec; 47(10):779-87. PubMed ID: 26462858
[TBL] [Abstract][Full Text] [Related]
15. [Effect of M007 mediated photodynamic therapy on proliferation of human osteosarcoma MG63 cells in vitro].
Zhou YK; Wu WZ; Zhang L; Yang CH; Wang YP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):41-5. PubMed ID: 22455129
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats.
Krueger T; Pan Y; Tran N; Altermatt HJ; Opitz I; Ris HB
Lasers Surg Med; 2005 Oct; 37(4):271-7. PubMed ID: 16245295
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies.
Ris HB; Altermatt HJ; Nachbur B; Stewart CM; Wang Q; Lim CK; Bonnett R; Althaus U
Lasers Surg Med; 1996; 18(1):39-45. PubMed ID: 8850464
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic action of meta-tetrahydroxyphenylchlorin (mTHPC) on an ovarian cancer cell line.
Gharehbaghi K; Kubin A; Grusch M; Gharehbaghi-Schnell E; Wierrani F; Jayaram HN; Grunberger W; Szekeres T
Anticancer Res; 2000; 20(4):2647-52. PubMed ID: 10953338
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia.
Campbell SM; Gould DJ; Salter L; Clifford T; Curnow A
Br J Dermatol; 2004 Nov; 151(5):1076-80. PubMed ID: 15541088
[TBL] [Abstract][Full Text] [Related]
20. Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2008 Jul; 40(5):300-11. PubMed ID: 18563776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
